Last Updated : March 22, 2024
Details
FilesGeneric Name:
Empagliflozin and metformin
Project Status:
Complete
Therapeutic Area:
Diabetes mellitus (Type 2)
Manufacturer:
Boehringer Ingelheim (Canada) Ltd.
Call for patient/clinician input open:
Brand Name:
Synjardy
Project Line:
Reimbursement Review
Project Number:
SR0489-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Performance Metric:
Achieved
Submission Type:
Initial
Indications:
Diabetes mellitus (Type 2)
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : March 22, 2024